Evidence map›Paper›PMID 40688243›Full record

ArticleHIV/AIDS (Auckland, N.Z.)2025

Cancer Awareness Among People Living with HIV (PLWH): Insights from an Italian Survey of Oncologists and Infectious Disease Specialists.

Davide Dalu, Rosaria Iardino, Emanuela Vaccher, Angioletta Lasagna, Margherita Digaetano, Alberto Giovanni Leone, Lorenzo Ruggieri, Eva Massari, Eva Blondeaux, Andrea Gori and 11 more

Abstract read
In one paragraph

Article in HIV/AIDS (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Davide DaluDepartment of Oncology, Luigi Sacco University Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Rosaria IardinoThe Bridge Foundation, Milan, Italy.
Emanuela VaccherInfectious Diseases and Tumors Unit, Department of Medical Oncology, Centro Di Riferimento Oncologico (CRO), IRCCS, National Cancer Institute, Aviano, Italy.
Angioletta LasagnaDepartment of Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Margherita DigaetanoClinic of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.
Alberto Giovanni LeoneMedical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Lorenzo RuggieriDepartment of Oncology, Luigi Sacco University Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.ORCID 0000-0002-9972-2761
Eva MassariThe Bridge Foundation, Milan, Italy.
Eva BlondeauxClinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Andrea GoriDepartment of Pathophysiology and Transplantation, University of Milan, Milano, Italy.
Cristina MussiniDivision of Infectious Diseases, University of Modena, Modena, Italy.
Giuliano RizzardiniDepartment of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Matteo BassettiClinic of Infectious Diseases, IRCCS Policlinico San Martino Hospital, University of Genoa, Genoa, Italy.
Antonio Di BiagioClinic of Infectious Diseases, IRCCS Policlinico San Martino Hospital, University of Genoa, Genoa, Italy.ORCID 0000-0003-1436-5089
Claudio M MastroianniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Luisa BrogonzoliThe Bridge Foundation, Milan, Italy.
Mario CascioEuropean AIDS Treatment Group (EATG), Brussels, Belgium.
Francesco PerroneClinical Trial Unit, Istituto Nazionale Tumori, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione G Pascale, Naples, Italy.
Saverio CinieriMedical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, Brindisi, Italy.
Giordano D BerettaMedical Oncology, Santo Spirito Hospital, Pescara, Italy.
Nicla La VerdeDepartment of Oncology, Luigi Sacco University Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Since the mid-1990s, the adoption of combined antiretroviral therapy (cART) has significantly reduced HIV-related mortality and morbidity. Nevertheless, cancer continues to be the leading cause of death in people living with HIV (PLWH). We conducted a survey to assess the knowledge and inter-disciplinarity among the Italian oncologists and infectious disease specialists in the cancer prevention and treatment of PLWH. Materials and Methods: All the members of AIOM, SIMIT and SITA who are oncologists and infectious disease specialists were invited via email. A survey with 24 queries was administered using a web-based platform. Data were analysed with the chi-square or Fisher exact tests to explore any significant difference between the two specialist subgroups. Results: From April to June 2023, 182 participants filled in the questionnaires. A low rate of respondents from each scientific society was reported (3% for AIOM, 8% from SIMIT and 2% from SITA). All interviewees agreed that HIV infection was a relevant risk factor for cancer (95.1%) and that PLWH had limited access to clinical trials (73.1%). More than a third of oncologists worked in a hospital without an infectious diseases department, using a remote method of communication for interdisciplinary discussion (telephone and Email were used in 64.5% of cases). Eighty-four percent of the oncologists vs 51.4% of the infectious disease specialists had in charge less than 5 patients with HIV during the previous year. Conclusion: The results of this survey underscore the opportunity for education, interdisciplinary collaboration, and organizational support to optimize cancer care for PLWH. A Hub&Spoke model could represent a potential facilitation to build-up in the near future through inter-societal collaboration.

Indexed as

cancerchemotherapyHIVItalyPLWHsurvey

Identifiers

PMID40688243
PMCPMC12275914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.